Clinical Outcome of Third-Line Pazopanib in a Patient with Metastatic Renal Cell Carcinoma.

Case Rep Oncol Med · 2015 · PMC4698998 · PMID 26798533

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Nevertheless, these data have showed a trend towards improved survival, mostly achieved by the application of multimodality treatment, which consists of surgery, WBRT, or SRS administration with concomitant or sequential TKI therapy.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.